Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
Erlotinib Hydrochloride
DOI:
10.1097/jto.0b013e318227e8c6
Publication Date:
2011-10-04T21:06:56Z
AUTHORS (11)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (104)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....